ATLASRocket Pharmaceuticals (RCKT) earnings date: Nov 5, 2026
Rocket Pharmaceuticals (RCKT) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026, after the close. Analysts expect EPS of -$0.39.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on RCKT
| Last price | $2.44 (0.0%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.2% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Rocket Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Rocket Pharmaceuticals reports on Nov 5, 2026. One email the day before, with ATLAS’s read on Rocket Pharmaceuticals. You can switch it off at any time.
Alert me before RCKT reportsFree to start. Creating an account takes under a minute.
Notify me when Rocket Pharmaceuticals reports
Track RCKT free Add Rocket Pharmaceuticals to a free ATLAS watchlist and see its next report date in one place.
RCKT earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.39 |
| Last report | Aug 10, 2026 · Miss |
| Beat rate (last 4 reports) | 3 of 4 (75%) |
| Average EPS surprise | -53.8% |
| Average move around a report | ±7.3% (last 4) |
| Sector | Healthcare · Biotechnology |
Rocket Pharmaceuticals earnings history: last 4 reports
Rocket Pharmaceuticals last reported on Aug 10, 2026: EPS of -$0.38 against an estimate of $0.27 (-240.7% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 10, 2026 | $0.27 | -$0.38 | -240.7% | Miss | -3.1% |
| May 7, 2026 | -$0.43 | -$0.42 | +2.3% | Beat | -6.0% |
| Feb 26, 2026 | -$0.42 | -$0.38 | +9.5% | Beat | +15.7% |
| Nov 6, 2025 | -$0.52 | -$0.45 | +13.5% | Beat | -4.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for RCKT
See the fair value, the probability range and the earnings history of Rocket Pharmaceuticals on its ATLAS page.
Rocket Pharmaceuticals (RCKT) stock analysisPlans from €3.99 a month.
Rocket Pharmaceuticals earnings: frequently asked questions
When does Rocket Pharmaceuticals (RCKT) report earnings?
Rocket Pharmaceuticals is scheduled to report on Thursday, November 5, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for RCKT?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.39 per share (USD). Estimates can change before the report.
How often does RCKT beat earnings estimates?
Of its last 4 reports with a recorded result, Rocket Pharmaceuticals beat the EPS estimate 3 times; the average surprise was -53.8%. Past results do not predict the next one.
How much does RCKT move around earnings?
Over its last 4 reports the stock moved an average of 7.3% (absolute, from the close before the report day to the close after it), and finished higher 1 of 4 times.
Did Rocket Pharmaceuticals beat earnings estimates last quarter?
Rocket Pharmaceuticals last reported on Aug 10, 2026: EPS of -$0.38 against an estimate of $0.27 (-240.7% surprise), a miss.
How much does RCKT usually move in a day?
On a normal trading day the ATLAS model puts RCKT’s one-day range at about ±4.2%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer